Singer, M., C.S. Deutschman, C.W. Seymour, et al. 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315: 801–810.

Article  CAS  Google Scholar 

Iwashyna, T.J., C.R. Cooke, H. Wunsch, and J.M. Kahn. 2012. Population burden of long-term survivorship after severe sepsis in older Americans. Journal of the American Geriatrics Society 60: 1070–1077.

Article  Google Scholar 

Cecconi, M., L. Evans, M. Levy, and A. Rhodes. 2018. Sepsis and septic shock. Lancet 392: 75–87.

Article  Google Scholar 

Iwashyna, T.J., E.W. Ely, D.M. Smith, and K.M. Langa. 2010. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304: 1787–1794.

Article  CAS  Google Scholar 

Strnad, P., F. Tacke, A. Koch, and C. Trautwein. 2017. Liver - guardian, modifier and target of sepsis. Nature Reviews. Gastroenterology & Hepatology 14: 55–66.

Article  CAS  Google Scholar 

Yan, J., and S. Li. 2014. The role of the liver in sepsis. International Reviews of Immunology 33: 498–510.

Article  CAS  Google Scholar 

Brun-Buisson, C., P. Meshaka, P. Pinton, and B. Vallet. 2004. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Medicine 30: 580–588.

Article  CAS  Google Scholar 

Terkeltaub, R.A., D.E. Furst, K. Bennett, K.A. Kook, R.S. Crockett, and M.W. Davis. 2010. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis and rheumatism 62: 1060–1068.

Article  CAS  Google Scholar 

Dinarello C.A, S.M. Wolff S.E. Goldfinger D.C. Dale and Alling D.W. 1974. Colchicine therapy for familial mediterranean fever. A double-blind trial. The New England journal of medicine 291: 934–937.

Imazio, M., A. Brucato, R. Cemin, et al. 2013. A randomized trial of colchicine for acute pericarditis. The New England journal of medicine 369: 1522–1528.

Article  CAS  Google Scholar 

Tardif, J.C., S. Kouz, D.D. Waters, et al. 2019. Efficacy and safety of low-dose colchicine after myocardial infarction. New England Journal of Medicine 381: 2497–2505.

Article  CAS  Google Scholar 

Forkosh, E., A. Kenig, and Y. Ilan. 2020. Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacology Research & Perspectives 8: e00616.

Article  CAS  Google Scholar 

Li, Z., G.S. Davis, C. Mohr, M. Nain, and D. Gemsa. 1996. Inhibition of LPS-induced tumor necrosis factor-alpha production by colchicine and other microtubule disrupting drugs. Immunobiology 195: 624–639.

Article  CAS  Google Scholar 

Schattner A., I. el-Hador T. Hahn, and Landau Z. 1997. Triple anti-TNF-alpha therapy in early sepsis: a preliminary report. Journal of International Medical Research 25: 112–116.

Fang, F., Y. Zhang, J. Tang, et al. 2019. Association of corticosteroid treatment with outcomes in adult patients with sepsis: A systematic review and meta-analysis. JAMA Internal Medicine 179: 213–223.

Article  Google Scholar 

Ilan, Y. 2016. Oral immune therapy: Targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Transl Immunology 5: e60.

Article  Google Scholar 

Ilan, Y. 2016. Review article: Novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. Alimentary Pharmacology & Therapeutics 44: 1168–1182.

Article  CAS  Google Scholar 

Ilan, Y. 2019. Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track. Journal of Leukocyte Biology 105: 463–472.

Article  CAS  Google Scholar 

Ilan, Y., K. Shailubhai, and A. Sanyal. 2018. Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: A novel gut-immune system-based therapy for metaflammation and NASH. Clinical and Experimental Immunology 193: 275–283.

Article  CAS  Google Scholar 

Drori, A., D. Rotnemer-Golinkin, S. Avni, et al. 2017. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. BMC Gastroenterology 17: 130.

Article  CAS  Google Scholar 

Almon, E., T. Khoury, A. Drori, et al. 2017. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. Journal of Immunological Methods 446: 21–29.

Article  CAS  Google Scholar 

Ilan, Y., A. Ben Ya’acov, Y. Shabbat, S. Gingis-Velitski, E. Almon, and Y. Shaaltiel. 2016. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis. World Journal of Gastroenterology 22: 8760–8769.

Article  CAS  Google Scholar 

Ben Ya’acov, A., Y. Lichtenstein, L. Zolotarov, and Y. Ilan. 2015. The gut microbiome as a target for regulatory T cell-based immunotherapy: Induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis. BMC Gastroenterology 15: 154.

Article  Google Scholar 

Khoury, T., A. Ben Ya’acov, Y. Shabat, L. Zolotarovya, R. Snir, and Y. Ilan. 2015. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. World Journal of Gastroenterology 21: 7443–7456.

Article  CAS  Google Scholar 

Ilan, Y. 2009. Oral tolerance: Can we make it work? Human Immunology 70: 768–776.

Article  CAS  Google Scholar 

Elinav, E., O. Pappo, M. Sklair-Levy, et al. 2006. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. The Journal of Pathology 208: 74–81.

Article  CAS  Google Scholar 

Ilan, Y., M. Margalit, M. Ohana, et al. 2005. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Human Immunology 66: 231–240.

Article  CAS  Google Scholar 

Margalit, M., and Y. Ilan. 2004. Oral immune regulation: A novel method for modulation of anti-viral immunity. Journal of Clinical Virology 31 (Suppl 1): S63–S68.

Article  CAS  Google Scholar 

Shibolet, O., R. Alper, L. Zlotogarov, et al. 2004. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. Oncology 66: 323–330.

Article  CAS  Google Scholar 

Nagler, A., M. Pines, U. Abadi, et al. 2000. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology 31: 641–648.

Article  CAS  Google Scholar 

Trop, S., D. Samsonov I. Gotsman R. Alper J. Diment and Ilan Y. 1999.  Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 29: 746–755.

Ilan, Y., B. Sauter, N.R. Chowdhury, et al. 1998. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology 27: 1368–1376.

Article  CAS  Google Scholar 

Lalazar, G., E. Zigmond, S. Weksler-Zangen, et al. 2017. Oral administration of beta-glucosylceramide for the treatment of insulin resistance and nonalcoholic steatohepatitis: Results of a double-blind, placebo-controlled trial. Journal of Medicinal Food 20: 458–464.

Article  CAS  Google Scholar 

Lalazar, G., M. Mizrahi, I. Turgeman, et al. 2015. Oral Administration of OKT3 MAb to Patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: Results of a phase IIa blinded placebo-controlled trial. Journal of Clinical Immunology 35: 399–407.

Article  CAS  Google Scholar 

Israeli, E., E. Zigmond, G. Lalazar, et al. 2015. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World Journal of Gastroenterology 21: 5685–5694.

Article  Google Scholar 

Israeli, E., E. Goldin, S. Fishman, et al. 2015. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn’s disease with low rate of side effects: Results of double blind Phase II clinical trial. Clinical and Experimental Immunology 181: 362–372.

Article  CAS  Google Scholar 

Halota, W., P. Ferenci, D. Kozielewicz, et al. 2015. Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: Results of a phase-2a placebo-controlled trial. Journal of Viral Hepatitis 22: 651–657.

Article  CAS  Google Scholar 

Mizrahi, M., Y. Shabat, A. Ben Ya’acov, et al. 2012. Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: Results of a phase I/II clinical trial in NASH. Journal of Inflammation Research 5: 141–150.

CAS  Google Scholar 

Israeli, E., and Y. Ilan. 2010. Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease. Therap Adv Gastroenterol 3: 23–30.

Article  CAS  Google Scholar 

Margalit, M., E. Israeli, O. Shibolet, et al. 2006. A double-blind clinical trial for treatment of Crohn’s disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: A patient-tailored approach. American Journal of Gastroenterology 101: 561–568.

Article  CAS  Google Scholar 

Israeli, E., E. Goldin, O. Shibolet, et al. 2005. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World Journal of Gastroenterology 11: 3105–3111.

Article  Google Scholar 

Shrum, B., R.V. Anantha, S.X. Xu, et al. 2014. A robust scoring system to evaluate sepsis severity in an animal model. BMC Research Notes 7: 233.

Article  Google Scholar 

Kleiner, D.E., E.M. Brunt, M. Van Natta, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313–1321.

Article  Google Scholar 

Koskinas, J., I.P. Gomatos, D.G. Tiniakos, et al. 2008. Liver histology in ICU patients dying from sepsis: A clinico-pathological study. World Journal of Gastroenterology 14: 1389–1393.

Article  CAS  Google Scholar 

Zhang, T., L. Yu-Jing, and T. Ma. 2022. The immunomodulatory function of adenosine in sepsis. Frontiers in Immunology 13: 936547.